Importantly, PI3K/AKT/mTOR is critical to maintaining the CSC population in various cancers, including nasopharyngeal carcinoma,209 glioma,210 pancreatic cancer,211 lung cancer,212 prostate,213 and breast cancer.214. Here, AKT1 is linked to central nervous system cancer.